Incidence and predictors of upgrading and up staging among 10,000 contemporary patients with low risk prostate cancer KT Dinh, BA Mahal, DR Ziehr, V Muralidhar, YW Chen, VB Viswanathan, ... The Journal of urology 194 (2), 343-349, 2015 | 135 | 2015 |
The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act BA Mahal, AA Aizer, DR Ziehr, AS Hyatt, C Lago-Hernandez, YW Chen, ... Prostate cancer and prostatic diseases 17 (3), 273-279, 2014 | 68 | 2014 |
Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States. BAV Mahal, YW Chen, V Muralidhar, AR Mahal, TK Choueiri, KE Hoffman, ... Journal of Clinical Oncology 35 (6_suppl), 18-18, 2017 | 60 | 2017 |
Gleason score 5+ 3= 8 prostate cancer: much more like Gleason score 9? BA Mahal, V Muralidhar, YW Chen, TK Choueiri, KE Hoffman, JC Hu, ... BJU international 118 (1), 95-101, 2016 | 57 | 2016 |
National Trends in Admission for Aspiration Pneumonia in the United States, 2002–2012 CP Wu, Y Chen, MJ Wang, E Pinelis Annals of the American Thoracic Society 14 (6), 874-879, 2017 | 56 | 2017 |
Prostate brachytherapy case volumes by academic and nonacademic practices: Implications for future residency training PF Orio III, PL Nguyen, I Buzurovic, DW Cail, YW Chen International Journal of Radiation Oncology* Biology* Physics 96 (3), 624-628, 2016 | 56 | 2016 |
Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer YW Chen, BA Mahal, V Muralidhar, M Nezolosky, CJ Beard, RB Den, ... International Journal of Radiation Oncology* Biology* Physics 94 (4), 683-690, 2016 | 56 | 2016 |
Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer PL Nguyen, NE Martin, V Choeurng, B Palmer-Aronsten, T Kolisnik, ... Prostate cancer and prostatic diseases 20 (2), 186-192, 2017 | 55 | 2017 |
Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice? V Muralidhar, BS Rose, YW Chen, MD Nezolosky, PL Nguyen International Journal of Radiation Oncology* Biology* Physics 96 (2), 313-317, 2016 | 52 | 2016 |
The decreased use of brachytherapy boost for intermediate and high-risk prostate cancer despite evidence supporting its effectiveness PF Orio III, PL Nguyen, I Buzurovic, DW Cail, YW Chen Brachytherapy 15 (6), 701-706, 2016 | 43 | 2016 |
Association Between Older Age and Increasing Gleason Score V Muralidhar, DR Ziehr, BA Mahal, YW Chen, MD Nezolosky, ... Clinical genitourinary cancer 13 (6), 525-530. e3, 2015 | 37 | 2015 |
National sociodemographic disparities in the treatment of high‐risk prostate cancer: Do academic cancer centers perform better than community cancer centers? BA Mahal, YW Chen, V Muralidhar, AR Mahal, TK Choueiri, KE Hoffman, ... Cancer 122 (21), 3371-3377, 2016 | 30 | 2016 |
COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors YW Chen, MD Tucker, KE Beckermann, WT Iams, BI Rini, DB Johnson European Journal of Cancer 155, 291-293, 2021 | 29 | 2021 |
National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base study. Mahal BA, Chen YW, Efstathiou JA, Muralidhar V, Hoffman KE, Yu JB, Feng FY ... Cancer, 2016 | 29 | 2016 |
Individual patient data analysis of randomized clinical trials: impact of black race on castration-resistant prostate cancer outcomes DE Spratt, YW Chen, BA Mahal, JR Osborne, SG Zhao, TM Morgan, ... European Urology Focus 2 (5), 532-539, 2016 | 28 | 2016 |
Travel distance and stereotactic body radiotherapy for localized prostate cancer BA Mahal, YW Chen, RV Sethi, OA Padilla, DD Yang, J Chavez, ... Cancer 124 (6), 1141-1149, 2018 | 25 | 2018 |
Risk of prostate cancer mortality in men with a history of prior cancer KT Dinh, BA Mahal, DR Ziehr, V Muralidhar, YW Chen, VB Viswanathan, ... BJU international 117 (6B), E20-E28, 2016 | 24 | 2016 |
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma MD Tucker, LC Brown, YW Chen, C Kao, N Hirshman, EN Kinsey, ... Biomarker Research 9 (1), 1-9, 2021 | 23 | 2021 |
Significant increase in prostatectomy and decrease in radiation for clinical T3 prostate cancer from 1998 to 2012 MD Nezolosky, KT Dinh, V Muralidhar, BA Mahal, YW Chen, CJ Beard, ... Urologic Oncology: Seminars and Original Investigations 34 (2), 57. e15-57. e22, 2016 | 20 | 2016 |
Cost-effectiveness of Management Options for Small Renal Mass Y Wang, YW Chen, JJ Leow, AC Levy, SL Chang, FH Gelpi American Journal of Clinical Oncology 39 (5), 484-490, 2016 | 19 | 2016 |